-
Mashup Score: 11FDA OCE expert presentations at public meetings - 3 hour(s) ago
OCE experts regularly join colleagues to participate in major conferences.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0DaVinci Laboratories Issues Allergy Alert on Undeclared Shellfish Allergen in Amyloid Complete Product Lot 549853001 - 23 hour(s) ago
DaVinci Laboratories, a division of FoodScience, LLC of Williston, Vermont is recalling 72 bottles of Amyloid Complete because it may contain undeclared shellfish (Shrimp and Crab). People who have an allergy or severe sensitivity to shellfish run the risk of serious or life-threatening allergic rea
Source: www.fda.govCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 1Texas Pecan Issues Allergy Alert on Undeclared Tree Nuts (Not Named Individually), Soy, Dairy(Milk), Sesame and Wheat Not Named in Product - 24 hour(s) ago
Texas Pecan of Dallas TX is recalling 1 Lb and 8 oz products because it may contain an undeclared allergen. People who have an allergy or severe sensitivity to (tree nuts, peanuts, almonds, brazils, cashews, filberts, macadamias, pistachios, pecans, pine nuts, walnuts, soy, dairy (milk), sesame and
Source: www.fda.govCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 1
Texas Pecan of Dallas TX is recalling 1 Lb and 8 oz products because it may contain an undeclared allergen. People who have an allergy or severe sensitivity to (tree nuts, peanuts, almonds, brazils, cashews, filberts, macadamias, pistachios, pecans, pine nuts, walnuts, soy, dairy (milk), sesame and
Source: www.fda.govCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 20FDA Issues Final Guidance to Clarify “Remanufacturing” of Devices that Need Maintenance or Repair - 1 day(s) ago
FDA issued final guidance clarifying the definition of “remanufacturing” for reusable devices needing maintenance or repair.
Source: www.fda.govCategories: General Medicine News, General NewsTweet-
Today, we issued final guidance to provide the medical device industry clarity on the definition of “remanufacturing” for reusable devices needing maintenance or repair. https://t.co/Da2sLYsdi8 The final guidance seeks to ensure that there is consistency regarding what… https://t.co/pz8F0iuihH https://t.co/TgwjHNczSq
-
-
Mashup Score: 4OCE Oncology News - 2 day(s) ago
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13FDA to Hold Listening Session as Part of Broader Work to Optimize Use of, and Processes for, Advisory Committees - 2 day(s) ago
FDA will host a listening session in June as part of broader work to optimize the use of, and processes, for advisory committees.
Source: www.fda.govCategories: General Medicine News, General NewsTweet
-
Mashup Score: 39Search for FDA Guidance Documents - 3 day(s) ago
Search for official FDA guidance documents and other regulatory guidance for all topics
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 18FDA Roundup: May 7, 2024 - 3 day(s) ago
FDA Roundup: May 7, 2024
Source: www.fda.govCategories: General Medicine News, General NewsTweet-
Check out the latest FDA Roundup, our at-a-glance summary of agency updates: https://t.co/SQBtX76C24 Today we announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by… https://t.co/LwRqNFoKSz https://t.co/kFMFf4hDmV
-
-
Mashup Score: 0FDA updates warnings for fluoroquinolone antibiotics - 3 day(s) ago
FDA issued a safety warning that fluoroquinolone antibiotic use has been associated with aortic aneurysms and dissection of aortic aneurysms. Health care professionals should avoid prescribing fluoroquinolone antibiotics to patients who have an aortic aneurysm or are at risk for an aortic aneurysm,
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet
FDA Oncology experts will be speaking at the @AACR Annual Meeting April 5-9 in San Diego! Put the dates and times on your calendar! OCE Public Presentations https://t.co/pNCjh1VzRP